Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Riikka Oksala"'
Autor:
Riikka Huhtaniemi, Petra Sipilä, Arttu Junnila, Riikka Oksala, Matias Knuuttila, Arfa Mehmood, Eija Aho, Teemu D. Laajala, Tero Aittokallio, Asta Laiho, Laura Elo, Claes Ohlsson, Malin Hagberg Thulin, Pekka Kallio, Sari Mäkelä, Mika V.J. Mustonen, Matti Poutanen
Publikováno v:
iScience, Vol 25, Iss 5, Pp 104287- (2022)
Summary: Antiandrogen treatment resistance is a major clinical concern in castration-resistant prostate cancer (CRPC) treatment. Using xenografts of VCaP cells we showed that growth of antiandrogen resistant CRPC tumors were characterized by a higher
Externí odkaz:
https://doaj.org/article/125d518783f44b70a3bc79f19094057c
Autor:
Mari Karimaa, Reetta Riikonen, Henna Kettunen, Päivi Taavitsainen, Meri Ramela, Marcin Chrusciel, Stefan Karlsson, Petteri Rummakko, Outi Simola, Gerd Wohlfahrt, Pasi Hakulinen, Annamari Vuorela, Heikki Joensuu, Tapio Utriainen, Karim Fizazi, Riikka Oksala
Publikováno v:
Molecular Cancer Therapeutics. 21:1765-1776
Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all steroid hormones, because CYP11A is the only enzyme that catalyses
Autor:
Riikka Oksala, Karim Fizazi, Tapio Utriainen, Heikki Joensuu, Annamari Vuorela, Pasi Hakulinen, Gerd Wohlfahrt, Outi Simola, Petteri Rummakko, Stefan Karlsson, Marcin Chrusciel, Meri Ramela, Päivi Taavitsainen, Henna Kettunen, Reetta Riikonen, Mari Karimaa
Supplementary Data from First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46051e52dfa8aaf74a566175a5384ef4
https://doi.org/10.1158/1535-7163.22523826
https://doi.org/10.1158/1535-7163.22523826
Autor:
Pekka J. Kallio, Murali Ramachandra, Nanduri Srinivas, Ravi K. Ujjinamatada, Subhendu Mukherjee, Samiulla Dhodheri, Thomas Anthony, Nagaraj Gowda, Rashmi Nair, Jiju Mani, Raghuveer K. Ramachandra, Kishore Narayanan, Shekar Chelur, Srinivasan Rajagopalan, Susanta Samajdar, Timo Korjamo, Riikka Oksala, Stefan Karlsson, Gerd Wohlfahrt, Tero Linnanen, Mari L. Björkman, Tarja Ikonen, Anu-Maarit Moilanen, Tim H. Holmström
Supplementary table S1 shows the effect of ODM-203 in a large kinase panel. Supplementary figure S1 shows how ODM-203 is synthesized. Supplementary figure S2 shows the effect of ODM-203 on FRS2 phosphorylation. Supplement figure S3 shows the effect o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a4b40ece62b019671a48c99c70cd8b
https://doi.org/10.1158/1535-7163.22505722
https://doi.org/10.1158/1535-7163.22505722
Autor:
Pekka J. Kallio, Murali Ramachandra, Nanduri Srinivas, Ravi K. Ujjinamatada, Subhendu Mukherjee, Samiulla Dhodheri, Thomas Anthony, Nagaraj Gowda, Rashmi Nair, Jiju Mani, Raghuveer K. Ramachandra, Kishore Narayanan, Shekar Chelur, Srinivasan Rajagopalan, Susanta Samajdar, Timo Korjamo, Riikka Oksala, Stefan Karlsson, Gerd Wohlfahrt, Tero Linnanen, Mari L. Björkman, Tarja Ikonen, Anu-Maarit Moilanen, Tim H. Holmström
Alterations in the gene encoding for the FGFR and upregulation of the VEGFR are found often in cancer, which correlate with disease progression and unfavorable survival. In addition, FGFR and VEGFR signaling synergistically promote tumor angiogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0ba784729eaeca665669c7e27a87040
https://doi.org/10.1158/1535-7163.c.6538162.v1
https://doi.org/10.1158/1535-7163.c.6538162.v1
Autor:
Matti Poutanen, Riikka Huhtaniemi, Sari Mäkelä, Matias Knuuttila, Claes Ohlsson, Riikka Oksala, Laura L. Elo, Pekka Kallio, Arfa Mehmood, Eija Aho, Petra Sipilä, Asta Laiho, Tero Aittokallio, Daniel Nicorici, Teemu D. Laajala, Mika Mustonen
Publikováno v:
American Journal of Pathology. 188(12):2890-2901
The role of adrenal androgens as drivers for castration-resistant prostate cancer (CRPC) growth in humans is generally accepted; however, the value of preclinical mouse models of CRPC is debatable, because mouse adrenals do not produce steroids activ
Autor:
Annamari Vuorela, Petteri Rummakko, Karim Fizazi, Riikka Oksala, Päivi Taavitsainen, Marcin Chrusciel, Mari Karimaa, Suvi Mansikka-Savolainen, Henna Kettunen, Outi Simola, Meri Ramela, Gerd Wohlfahrt
Publikováno v:
Cancer Research. 81:1250-1250
Several new treatments have been developed to target the androgen signaling axis in CRPC over the last decade. Despite the new treatment options, the challenge for managing CRPC is the limited duration of clinical benefit from treatments due to prima
Autor:
Meri Ramela, Reetta Riikonen, Riikka Oksala, Kati Rasanen, Mika Mustonen, Gerd Wohlfahrt, Mari Karimaa, Pirjo Vehmaan-Kreula, Petteri Rummakko
Publikováno v:
Endocrine Abstracts.
Autor:
Riikka Oksala, Reetta Riikonen, Kati Rasanen, Mari Karimaa, Pirjo Vehmaan-Kreula, Gerd Wohlfahrt, Petteri Rummakko, Meri Ramela, Mika Mustonen
Publikováno v:
Journal of the Endocrine Society
Background: Prostate cancer is a major global challenge due to the increasing number of aging population and frequency of diagnosis. During the past decade new treatments have been targeted to the androgen signaling axis either by inhibiting the bind
Autor:
Petteri Rummakko, H-M. Metsänkylä, Riikka Oksala, Reetta Riikonen, S. Mansikka-Savolainen, Mari Karimaa, Meri Ramela
Publikováno v:
Annals of Oncology. 31:S11